• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchImmuPharma
    Picture of ImmuPharma logo

    IMM — ImmuPharma Share News

    3.70p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      £23.14m
    • Enterprise Value
      £22.44m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IMM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IMM Dividends
    • £2.91m fundraising; related party transactions

      13/02/2025 07:00
    • Brief: Immupharma Says Not Aware Of Any Reason For Share Price Movements

      28/01/2025 13:10
    • Response to Share Price Movement

      28/01/2025 12:57
    • UK's ImmuPharma rises on "groundbreaking" finding in autoimmune diseases

      09/01/2025 08:32
    • Brief: Immupharma Reports Breakthrough Findings Into Autoimmune Diseases

      09/01/2025 07:24
    • IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE

      08/01/2025 07:00
    • Holding(s) in Company

      10/12/2024 14:36
    • Brief: ImmuPharma H1 net income GBP -400 thousand

      09/09/2024 07:23
    • Half-year Report

      09/09/2024 07:00
    • Holding(s) in Company

      06/08/2024 13:41
    • Holding(s) in Company

      06/06/2024 16:20
    • Notice of AGM & Annual Report & Accounts

      05/06/2024 14:01
    • Final Results

      05/06/2024 07:00
    • Realisation-c£1.5m on sale of shares in Incanthera

      03/06/2024 10:09
    • Holding(s) in Company

      03/05/2024 07:00
    • Immupharma At Bio: EQUITY 2024 12-14 May

      24/04/2024 07:12
    • Grant of Share Options

      19/04/2024 07:00
    • Brief: Immupharma Initiates New Intellectual Property Strategy

      02/04/2024 07:25
    • Incanthera provides Comm'l Update/Revenue F'casts

      25/03/2024 07:25
    • Grant of Share Options

      19/03/2024 07:00
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.